project id: TCGA-BLCA; case submitter id: TCGA-DK-A2I2; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.93; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.0; age at index: 63; days to birth: -23116; days to death: 237; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1947; year of death: 2010; age at diagnosis: 23116; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 217; days to sample procurement: 0; initial weight: 530.0; portion submitter id: TCGA-DK-A2I2-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;